Case Reports in Immunology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 0.9 | Q4 | 5.5% | 0.261 | Q4 | 38.4% |
| 2024 | 1.5 | Q4 | 15.8% | 0.359 | Q4 | 51.3% |
| 2023 | 0.7 | Q4 | 5.1% | 0.742 | Q2 | 77.4% |
| 2022 | 1.0 | 9.4% | 0.242 | Q4 | 43.9% | |
| 2021 | — | 14.6% | — | 9.3% | ||
| 2020 | — | — | 0.125 | Q4 | 13.2% | |
| 2019 | — | — | 0.250 | Q4 | 46.4% | |
| 2018 | — | — | 0.138 | Q4 | 18.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2090-6609
ISSN
2090-6617
country
GBcoverage
2016-2017, 2019-2026